In oropharyngeal squamous cell carcinoma, TIBs may recruit CD8+ T cells through CXCL9 and high-density CD20+ B-cell/CD8+ T-cell aggregation is correlated with good prognosis in patients 135. This evidence concerns the gene CD8A and oropharynx squamous cell carcinoma.